Skip to content

The effect of abdominal massage on feeding tolerance

The effect of abdominal massage on feeding tolerance via intermittent nasogastric feeding tube in critically ill patients.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2014090618815N1
Enrollment
80
Registered
2015-12-28
Start date
2014-10-07
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: Coma. Condition 2: Head trauma. Condition 3: Brain tumor. Condition 4: Malignant Brain tumor. Condition 5: Alzheimer. Coma, unspecified Post- concussional syndrome Benign neoplasm of brain and other parts of central nervous system Malignant neoplasm of brain Alzheimer disease

Interventions

Intervention 1: Abdominal massage 30 minutes before nasogastric tube feeding on interventional group. Intervention 2: No intervention in control group.
Abdominal massage 30 minutes before nasogastric tube feeding on interventional group.

Sponsors

Vice Chancellor for Research of Tehran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Subjects who were being fed intermittently enterally via a nasogastric tube; Over age 18 years up to 70 years; Recently started on intermittent enteral feeding, maximum after giving 3 feed; Have not received metoclopramide, erythromycin, cisapride, and anticholinergic agents; Have not received radiotherapy treatment and surgery on the abdominal region in the previous 6 weeks; Have no contraindication to abdominal massage for examples: cellulitis, abdominal mass, peritonitis, abdominal aneurysm, ascites, diverticulitis, probability of thromboembolic events in recent one year, positive history and probability of DVT in one recent year. Exclusion criteria: Have two times consecutively vomiting( less than 12 hours); Develop diarrhea more than 3 times a day; Receive metoclopramide for vomiting; Discharge patients from ICU or death less than 3 days; Make patients NPO more than 12 hours for procedures or laboratory tests.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Gastric residual volume. Timepoint: before every feeding. Method of measurement: with 50 cc feeding syring.;Diarrhea. Timepoint: Every shift. Method of measurement: Frequency.;Vomiting. Timepoint: Every shift. Method of measurement: Frequency.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactRoya Haddadi

Tehran University of Medical Sciences

haddadi@razi.tums.ac.ir+98 21 6692 7171

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026